About
Technology
Issues
FAQ
Links
Official Page
Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
